ADD CONDITION
Aspirin
Last content change checked dailysee data sync status
- Active ingredient
- Aspirin 81 mg/81 mg – 325 ng
- Reference brand
- Aspirin
- Drug classes
- Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor
- Dosage forms
- Capsule
- Powder
- Strip
- Tablet
- Tablet, Chewable
- Tablet, Coated
- Tablet, Delayed Release
- Tablet, Effervescent
- Tablet, Film Coated
- Tablet, Orally Disintegrating
- Route
- Oral
- Prescription status
- OTC (over the counter)
- Marketed in the U.S.
- Since 1983
- Label revision date
- March 23, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Active ingredient
- Aspirin 81 mg/81 mg – 325 ng
- Reference brand
- Aspirin
- Drug classes
- Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor
- Dosage forms
- Capsule
- Powder
- Strip
- Tablet
- Tablet, Chewable
- Tablet, Coated
- Tablet, Delayed Release
- Tablet, Effervescent
- Tablet, Film Coated
- Tablet, Orally Disintegrating
- Route
- Oral
- Prescription status
- OTC (over the counter)
- CSA schedule
- Not a scheduled drug
- Marketed in the U.S.
- Since 1983
- Label revision date
- March 23, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Aspirin is a widely used pain reliever classified as a nonsteroidal anti-inflammatory drug (NSAID). It is commonly taken in low doses, such as 81 mg, for the temporary relief of minor aches and pains, including headaches, muscle pain, toothaches, menstrual pain, and discomfort associated with colds. Aspirin works by reducing inflammation and pain in the body.
Due to its delayed action, aspirin may not provide immediate relief for headaches or other symptoms that require quick action. It is important to consult with your doctor before using aspirin, especially for heart-related issues, as it may not be suitable for everyone.
Uses
You can use this medication for the temporary relief of minor aches and pains, including headaches, muscle pain, toothaches, menstrual pain, and discomfort associated with colds. It may also help alleviate minor arthritis pain. However, keep in mind that due to its delayed action, this product will not provide fast relief for headaches or other symptoms that require immediate attention.
If you have any questions about additional uses for this medication, or if you need to use it for more than 10 days, consult your doctor for guidance.
Dosage and Administration
You should take aspirin with a full glass of water. For adults and children aged 12 years and older, the recommended dosage is to take 4 to 8 tablets every 4 hours while symptoms persist, but do not exceed 48 tablets in a 24-hour period unless directed by a doctor. If you are using a different formulation, such as chewable tablets, make sure to chew or crush them completely before swallowing.
For those aged 60 years and older, the dosage may be lower, so consult a doctor for specific recommendations. If you are giving aspirin to children under 12 years, you should consult a doctor before use. Always follow the instructions on the specific product you are using, and do not exceed the recommended dosage.
What to Avoid
You should avoid using aspirin if you are allergic to it or any other pain reliever/fever reducer. This includes any history of allergic reactions to aspirin or its ingredients. Additionally, do not use aspirin for at least 7 days after a tonsillectomy or oral surgery unless directed by a doctor. If you experience any signs of an allergic reaction or stomach bleeding (such as feeling faint, vomiting blood, or having bloody or black stools), seek medical help immediately. Always follow the recommended dosage and consult a healthcare professional if you have any concerns.
Side Effects
You should be aware of several potential side effects when using aspirin. A serious concern is Reye's syndrome, a rare but severe illness that can occur in children and teenagers recovering from chickenpox or flu-like symptoms. If you notice changes in behavior accompanied by nausea and vomiting, seek medical attention immediately.
Aspirin can also cause severe allergic reactions, which may include symptoms like hives, facial swelling, asthma (wheezing), and shock. Additionally, it contains a nonsteroidal anti-inflammatory drug (NSAID) that can lead to severe stomach bleeding, especially if you are over 60, have a history of stomach ulcers or bleeding, take blood thinners or steroids, consume three or more alcoholic drinks daily, or use other NSAIDs.
You should stop using aspirin and consult a doctor if you experience any signs of an allergic reaction or stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, or persistent stomach pain. Other concerning symptoms include worsening pain lasting more than 10 days, new symptoms, redness or swelling, and ringing in the ears or loss of hearing. Always consult a healthcare professional before using aspirin if you have existing health conditions or are taking other medications.
Warnings and Precautions
Reye's Syndrome: Do not use this product if you are a child or teenager recovering from chickenpox or flu-like symptoms. If you notice changes in behavior accompanied by nausea and vomiting, consult a doctor immediately, as these may be early signs of Reye's syndrome, a rare but serious illness.
Allergic Reactions: Aspirin can cause severe allergic reactions, which may include hives, facial swelling, asthma (wheezing), and shock. If you experience any of these symptoms, seek medical help right away.
Stomach Bleeding Warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which can lead to severe stomach bleeding. The risk is higher if you:
Are 60 years or older
Have a history of stomach ulcers or bleeding problems
Take blood-thinning medications (anticoagulants) or steroids
Consume three or more alcoholic drinks daily while using this product
Take more than directed or for longer than recommended
Consult a Doctor Before Use: If you have a history of stomach problems (like heartburn), high blood pressure, heart disease, liver cirrhosis, kidney disease, or asthma, ask your doctor before using this product. Also, consult a doctor if you are taking medications for diabetes, gout, or arthritis.
Stop Use and Call Your Doctor If:
You experience any signs of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, or stomach pain that does not improve.
An allergic reaction occurs.
Pain lasts more than 10 days or worsens.
Fever lasts more than 3 days or worsens.
You notice new symptoms, redness, or swelling.
You experience ringing in the ears or loss of hearing.
Emergency Help: In case of overdose, seek medical help immediately or contact a Poison Control Center at 1-800-222-1222. Quick medical attention is crucial for both adults and children, even if no symptoms are present.
Overdose
In the event of an overdose of aspirin, it is crucial to seek immediate medical help or contact a Poison Control Center at 1-800-222-1222. Overdosing on aspirin can lead to serious health issues, including symptoms such as nausea, vomiting, stomach pain, and in severe cases, liver damage. Quick medical attention is essential for both adults and children, even if no symptoms are initially apparent.
If you suspect an overdose, do not wait for symptoms to appear. Contact a healthcare professional or a Poison Control Center right away to ensure proper care and treatment.
Pregnancy Use
If you are pregnant or breastfeeding, it is crucial to consult a healthcare professional before using aspirin. Generally, it is advised not to take aspirin during the last three months of pregnancy unless specifically directed by a doctor, as it may lead to complications for the unborn child or during delivery. This includes any form of aspirin, such as tablets, chewables, or effervescent forms.
Additionally, avoid using aspirin at 20 weeks of pregnancy or later unless your doctor has given clear instructions to do so. The potential risks associated with aspirin during this period include problems for the developing baby and complications during childbirth. Always prioritize discussing any medication with your healthcare provider to ensure the safety of both you and your baby.
Lactation Use
If you are pregnant or breastfeeding, it is crucial to consult a healthcare professional before using aspirin. This is particularly important during the last three months of pregnancy, as using aspirin during this time may lead to complications for both you and your unborn child. Aspirin can potentially cause problems in the unborn child or complications during delivery, so always seek medical advice before taking it.
Pediatric Use
Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use any aspirin products due to the risk of Reye's syndrome, a rare but serious illness. If your child experiences changes in behavior accompanied by nausea and vomiting while using these products, consult a doctor immediately, as these may be early signs of Reye's syndrome.
For children under 12 years, it is essential to consult a doctor before using aspirin. For those aged 12 years and older, the typical dosing is 1 to 2 tablets every 4 to 6 hours, not exceeding 12 tablets in 24 hours unless directed by a doctor. Always keep aspirin out of reach of children, and in case of accidental overdose, seek medical help or contact a Poison Control Center right away.
Geriatric Use
If you are 60 years or older, it's important to be aware that many aspirin products, including various forms like chewable, coated, and delayed-release tablets, carry a warning about an increased risk of severe stomach bleeding. This risk is particularly heightened if you have a history of stomach problems (like heartburn), high blood pressure, heart disease, liver cirrhosis, or kidney disease.
For older adults, the recommended dosage for certain effervescent tablets is typically 2 tablets every 4 hours, not exceeding 4 tablets in 24 hours, unless directed by a doctor. Always consult your healthcare provider before using these medications, especially if you have any underlying health conditions or are taking other medications, as this can help ensure your safety and well-being.
Renal Impairment
If you have high blood pressure, heart disease, liver cirrhosis, or kidney disease, it's important to consult with your doctor before using any aspirin products. Many labels recommend this precaution, as these conditions can affect how your body processes the medication.
For those with renal impairment, dosage adjustments may be necessary, particularly if your creatinine clearance is below a certain level. Regular monitoring of kidney function is advised, especially for patients with severe renal impairment. Additionally, if you experience any signs of stomach bleeding, such as faintness, vomiting blood, or black stools, you should stop using the medication and seek medical advice, as these symptoms can be exacerbated by kidney issues. Always discuss your specific health conditions and medications with your healthcare provider to ensure safe use.
Hepatic Impairment
If you have high blood pressure, heart disease, liver cirrhosis (severe liver scarring), or kidney disease, it is important to consult with your doctor before using any aspirin products. This includes various forms such as tablets, chewables, and coated versions. Your doctor may recommend special monitoring or dosage adjustments due to potential changes in how your body processes the medication, especially if you have liver impairment.
Additionally, taking more than the recommended dose of aspirin can lead to liver damage. If you suspect an overdose, seek medical help immediately, as prompt attention is crucial for both adults and children, even if no symptoms are present. Always prioritize your health by discussing any concerns with your healthcare provider.
Drug Interactions
When using aspirin or products containing NSAIDs (nonsteroidal anti-inflammatory drugs), it's important to be aware of potential risks, particularly the chance of severe stomach bleeding. This risk increases if you are taking blood thinners (anticoagulants), steroids, or other NSAIDs like ibuprofen or naproxen. You should also be cautious if you are over 60, have a history of stomach ulcers or bleeding, or consume three or more alcoholic drinks daily while using these medications.
Before starting any aspirin regimen, consult your doctor or pharmacist, especially if you are taking medications for diabetes, gout, or arthritis, or if you have conditions like high blood pressure, heart disease, liver cirrhosis, or kidney disease. Discussing your medications and health conditions with a healthcare provider is crucial to ensure your safety and avoid harmful interactions.
Storage and Handling
To ensure the effectiveness of your aspirin products, store them at room temperature, ideally between 20°C to 25°C (68°F to 77°F). Some products allow for slight variations, with acceptable ranges from 15°C to 30°C (59°F to 86°F). It's important to keep them in a dry place, away from excessive heat and humidity, as temperatures above 40°C (104°F) can compromise their quality. Always check the packaging for the expiration date and lot number, and retain the carton for complete product information.
When handling, be cautious of the tamper-evident seals. Do not use any product if the seal is broken or missing, as this indicates potential contamination. If you have opened packets, avoid using them if they appear torn or damaged. Dispose of any unused portions responsibly, following local guidelines for medication disposal.
Uses and Indications
This drug is indicated for the temporary relief of minor aches and pains, including but not limited to headaches, muscle pain, toothaches, menstrual pain, backaches, and minor arthritis pain. It is also effective for pain and fever associated with colds. The product may be used as recommended by a doctor.
Due to its delayed action, this product will not provide fast relief of headaches or other symptoms requiring immediate attention. Patients are advised to consult their doctor regarding other potential uses for this medication.
Limitations of Use
This product should not be used for more than 10 days without consulting a doctor, as serious side effects may occur.
It is important to ask a doctor about other uses for this product, especially for specific conditions or prolonged use.
Special Populations
The product is not indicated for children under 12 years unless directed by a doctor.
Dosage and Administration
Adults and children 12 years and older are advised to take 4 to 8 tablets every 4 hours while symptoms persist, not to exceed 48 tablets in a 24-hour period unless directed by a healthcare professional. For those aged 60 years and older, the maximum dosage should not exceed 4 tablets in 24 hours.
For children under 12 years, it is recommended to consult a doctor before use.
All patients should drink a full glass of water with each dose. Tablets should be swallowed whole and not chewed or crushed, except for chewable formulations, which must be chewed completely before swallowing.
In cases where symptoms persist beyond 10 days, or if there is any uncertainty regarding the appropriate dosage, patients should seek medical advice.
Contraindications
Do not use if the patient is allergic to aspirin or any other pain reliever/fever reducer. Use is contraindicated in individuals who have ever had an allergic reaction to this product or any of its ingredients. Additionally, do not use this product for at least 7 days after tonsillectomy or oral surgery unless directed by a doctor.
Warnings and Precautions
Reye's Syndrome Warning Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. If changes in behavior with nausea and vomiting occur while using this product, consult a doctor immediately, as these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
Allergy Alert Aspirin may cause a severe allergic reaction, which may include:
Hives
Facial swelling
Shock
Asthma (wheezing)
Stomach Bleeding Warning This product contains an NSAID, which may cause severe stomach bleeding. The risk is higher if the user:
Is age 60 or older
Has had stomach ulcers or bleeding problems
Takes a blood thinning (anticoagulant) or steroid drug
Takes other drugs containing prescription or nonprescription NSAIDs (such as aspirin, ibuprofen, naproxen, or others)
Consumes 3 or more alcoholic drinks every day while using this product
Takes more or for a longer time than directed
General Precautions Ask a doctor before use if:
The stomach bleeding warning applies to you
You have a history of stomach problems, such as heartburn
You have high blood pressure, heart disease, liver cirrhosis, or kidney disease
You are taking a diuretic
You have asthma
You have not been drinking fluids or have lost a lot of fluid due to vomiting or diarrhea
Laboratory Tests No specific laboratory tests are mentioned.
Get Emergency Medical Help In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Quick medical attention is critical for adults as well as for children, even if no signs or symptoms are noticed.
Stop Taking and Call Your Doctor Stop use and ask a doctor if:
An allergic reaction occurs. Seek medical help right away.
You experience any of the following signs of stomach bleeding:
Feel faint
Vomit blood
Have bloody or black stools
Have stomach pain that does not get better
Pain gets worse or lasts more than 10 days
Fever gets worse or lasts more than 3 days
Redness or swelling is present
New symptoms occur
Ringing in the ears or loss of hearing occurs
These could be signs of a serious condition.
Side Effects
Patients using aspirin products should be aware of the following potential adverse reactions, which are categorized by seriousness and frequency.
Serious Adverse Reactions
Reye's Syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use aspirin. If changes in behavior accompanied by nausea and vomiting occur, medical consultation is advised as these may indicate early signs of Reye's syndrome, a rare but serious illness.
Severe Allergic Reactions: Aspirin may cause severe allergic reactions, which can include:
Hives
Facial swelling
Shock
Asthma (wheezing)
Stomach Bleeding: Aspirin contains an NSAID, which may lead to severe stomach bleeding. The risk is heightened in patients who:
Are age 60 or older
Have a history of stomach ulcers or bleeding problems
Are taking blood-thinning (anticoagulant) or steroid medications
Consume three or more alcoholic drinks daily while using aspirin
Take more than the recommended dose or for a longer duration than directed
Common Adverse Reactions
Patients should discontinue use and consult a healthcare provider if they experience any of the following symptoms, which may indicate serious conditions:
Signs of stomach bleeding:
Feeling faint
Vomiting blood
Having bloody or black stools
Experiencing stomach pain that does not improve
New symptoms arise
Pain persists or worsens beyond 10 days
Fever worsens or lasts more than 3 days
Redness or swelling occurs
Ringing in the ears or loss of hearing occurs
Additional Considerations
Consult a Doctor Before Use: Patients should seek medical advice if they have:
A history of stomach problems, such as heartburn
High blood pressure, heart disease, liver cirrhosis, or kidney disease
Asthma
Are taking diuretics or other medications for diabetes, gout, or arthritis
Pregnancy and Breastfeeding: Pregnant or breastfeeding individuals should consult a healthcare professional before using aspirin, particularly during the last three months of pregnancy, as it may cause complications for the unborn child or during delivery.
Patients are encouraged to report any adverse reactions to their healthcare provider to ensure appropriate management and care.
Drug Interactions
Aspirin and its formulations, including various brands and dosages, are associated with significant drug interactions primarily related to the risk of gastrointestinal bleeding.
Pharmacodynamic Interactions
Aspirin is classified as a nonsteroidal anti-inflammatory drug (NSAID) and may cause severe stomach bleeding, particularly when used in conjunction with:
Blood Thinning Agents: The risk of bleeding is heightened when aspirin is taken with anticoagulants (e.g., warfarin) or other blood thinners.
Steroid Medications: Concurrent use with steroid drugs can also increase the likelihood of gastrointestinal bleeding.
Other NSAIDs: The chance of stomach bleeding is further elevated if aspirin is taken alongside other NSAIDs, whether prescription or over-the-counter, such as ibuprofen or naproxen.
Clinical Considerations
Patients should be advised to consult a healthcare professional before using aspirin if they are:
Taking prescription medications for diabetes, gout, or arthritis.
Aged 60 years or older, as this demographic is at a higher risk for bleeding complications.
Consuming three or more alcoholic drinks daily while using aspirin, which can exacerbate the risk of gastrointestinal issues.
Monitoring Recommendations
Healthcare providers should monitor patients closely for signs of gastrointestinal bleeding, especially in those with a history of stomach ulcers or bleeding problems. Additionally, it is advisable to assess the patient's overall health status, including any history of heart disease, liver cirrhosis, kidney disease, or asthma, prior to initiating aspirin therapy.
In summary, while aspirin is effective for pain relief and anti-inflammatory purposes, its potential interactions necessitate careful consideration and monitoring to mitigate risks associated with gastrointestinal bleeding.
Pediatric Use
Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use aspirin products due to the risk of Reye's syndrome, a rare but serious illness. If changes in behavior accompanied by nausea and vomiting occur while using these products, a doctor should be consulted, as these symptoms may indicate the onset of Reye's syndrome.
For dosing recommendations:
Children under 12 years: Consult a doctor before use. Aspirin should not be used unless directed by a healthcare professional.
Adults and children 12 years and over:
Take 1 to 2 tablets every 4 hours or 3 tablets every 6 hours, not to exceed 12 tablets in 24 hours unless directed by a doctor.
Alternatively, take 4 to 8 tablets every 4 hours, not to exceed 48 tablets in 24 hours unless directed by a doctor.
It is important to keep aspirin products out of reach of children. In case of accidental overdose, medical help should be sought immediately or contact a Poison Control Center.
Geriatric Use
Elderly patients, particularly those aged 60 years and older, are at an increased risk of severe stomach bleeding when using products containing NSAIDs, including aspirin. It is crucial for healthcare providers to assess the individual risk factors of geriatric patients, especially those with a history of stomach problems, high blood pressure, heart disease, liver cirrhosis, or kidney disease.
For patients aged 60 and over, the recommended dosage for certain formulations is typically 2 tablets every 4 hours, not exceeding 4 tablets in 24 hours, unless otherwise directed by a physician. Healthcare providers should advise patients to consult a doctor before use if they have any of the aforementioned conditions or if they experience symptoms indicative of stomach bleeding, such as faintness, bloody or black stools, or persistent stomach pain.
In summary, careful monitoring and appropriate dose modifications are essential when prescribing NSAIDs to elderly patients to mitigate the risk of gastrointestinal complications.
Pregnancy
Pregnant patients should consult a healthcare professional before using aspirin or any aspirin-containing products. It is particularly important to avoid the use of aspirin during the last three months of pregnancy unless specifically directed by a physician, as it may lead to complications for the unborn child or during delivery.
Aspirin use at or after 20 weeks of gestation is also discouraged unless explicitly advised by a healthcare provider. Potential risks associated with aspirin during pregnancy include adverse fetal outcomes and complications during labor and delivery. Therefore, healthcare providers should carefully evaluate the necessity of aspirin therapy in pregnant patients and consider alternative treatments when appropriate.
Lactation
If lactating mothers are considering the use of aspirin, it is crucial to consult a healthcare professional prior to use. Aspirin is known to be excreted in breast milk, and while specific effects on breastfed infants are not detailed, caution is advised due to potential risks.
It is particularly important to avoid the use of aspirin during the last three months of pregnancy unless specifically directed by a healthcare provider, as it may lead to complications for the unborn child or during delivery. Additionally, the use of aspirin at 20 weeks of gestation or later should be approached with caution, as it may pose similar risks.
Healthcare professionals should weigh the benefits against potential risks when advising lactating mothers on the use of aspirin.
Renal Impairment
Patients with renal impairment should exercise caution when using aspirin products. It is recommended that these patients consult a healthcare professional prior to use, especially if they have conditions such as high blood pressure, heart disease, liver cirrhosis, or kidney disease.
For those with renal impairment, dosage adjustments may be necessary. Specifically, patients with a creatinine clearance of less than 30 mL/min may require a reduced dose. Regular monitoring of renal function is advised for patients receiving aspirin, particularly for those with known kidney problems or severe renal impairment.
Additionally, patients taking diuretics should inform their healthcare provider, as this may influence the management of their condition while using aspirin. It is crucial for patients to be vigilant for any signs of stomach bleeding, which may be exacerbated by kidney issues, and to seek medical advice if such symptoms occur.
In summary, careful consideration and monitoring are essential for patients with renal impairment when using aspirin, and they should always consult a healthcare professional for personalized guidance.
Hepatic Impairment
Patients with hepatic impairment should exercise caution when using aspirin. It is recommended that these patients consult a healthcare professional before use, particularly if they have high blood pressure, heart disease, liver cirrhosis, or kidney disease.
For patients with hepatic impairment, dosage adjustments may be necessary due to potential alterations in hepatic metabolism. Regular monitoring of liver function tests is advised to ensure safety and efficacy. Special precautions should be taken when administering aspirin to this population, as hepatic impairment may affect the drug's metabolism.
In cases of overdose, there is a risk of liver damage, and immediate medical attention is critical. Patients should be informed to seek help or contact a Poison Control Center if they suspect an overdose, even if no symptoms are present.
Overdosage
In the event of an overdose, immediate medical assistance should be sought by contacting a Poison Control Center at 1-800-222-1222 or by obtaining medical help right away. Quick medical attention is critical for both adults and children, even if no symptoms are observed.
Symptoms of an overdose may include nausea, vomiting, stomach pain, and in severe cases, may lead to serious complications such as metabolic acidosis and respiratory alkalosis. It is important to monitor for these symptoms and act promptly. Overdosage of aspirin can cause serious harm, and individuals should be aware that taking more than the recommended dose may result in liver damage.
In summary, in case of overdose, the following actions are recommended:
Seek immediate medical attention.
Contact a Poison Control Center.
Monitor for symptoms such as nausea, vomiting, and stomach pain.
Nonclinical Toxicology
Teratogenic Effects
Aspirin should not be used during the last three months of pregnancy unless specifically directed by a healthcare professional, as it may lead to complications for the unborn child or during delivery. This caution is particularly emphasized for use at 20 weeks of gestation or later.
Non-Teratogenic Effects
No specific non-teratogenic effects have been reported in the available data.
Nonclinical Toxicology
There are no specific nonclinical toxicology details provided in the available data.
Animal Pharmacology and Toxicology
No specific animal pharmacology and toxicology details have been reported in the available data.
Storage and Handling
A variety of aspirin products are available in different formulations, including coated, delayed release, and chewable tablets. These products are supplied in various packaging configurations, and specific storage conditions must be adhered to in order to maintain their efficacy.
Storage Conditions:
Most aspirin products should be stored at room temperature, typically between 20°-25°C (68°-77°F), with some allowing for excursions between 15°-30°C (59°-86°F).
Certain formulations may specify storage at 25°C (77°F) with similar temperature excursions permitted.
A few products can be stored at a broader range of 15-30°C (59-86°F).
It is essential to protect these products from excessive heat, particularly above 40°C (104°F), and humidity.
Handling Requirements:
Many products are packaged with tamper-evident seals; users should not use any product if the safety seal under the cap is broken or missing.
It is recommended to retain the carton for complete product information and warnings.
For chewable formulations, it is advised to keep the container tightly closed after use to maintain product integrity.
Users should discard any opened or torn packets to ensure safety and efficacy.
By following these guidelines, the quality and effectiveness of the aspirin products can be preserved throughout their shelf life.
Product Labels
The table below lists all over-the-counter labels containing aspirin. Use it to compare dosage forms, strengths, and uses across products.
More Details | |||||
|---|---|---|---|---|---|
DISCOUNT DRUG MART | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
HARRIS TEETER | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
Safrel Pharmaceuticals, LLC. | Tablet, Delayed Release | Oral | 81 mg | 2016 | |
Indications
| |||||
Advanced Rx LLC | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
Aidarex Pharmaceuticals LLC | Tablet, Delayed Release | Oral | 81 mg | 2007 | |
Indications
| |||||
FELICIFIC INC. | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
FELICIFIC INC. | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
Liberty Pharmaceuticals, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2007 | |
Indications
| |||||
Pharbest Pharmaceuticals, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2007 | |
Indications
| |||||
Rising Pharma Holdings, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
Zandi LLC | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
HealthLife of USA LLC | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
Pharbest Pharmaceuticals, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2019 | |
Indications
| |||||
Bi-Mart | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet, Coated | Oral | 81 mg | 2000 | |
Indications
| |||||
Sportpharm LLC | Tablet, Coated | Oral | 81 mg | 2026 | |
Indications
| |||||
TWIN MED LLC | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Delayed Release | Oral | 81 mg | 2010 | |
Indications
| |||||
ADVANCED FIRST AID, INC. | Tablet | Oral | 325 | 2015 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet, Effervescent | Oral | 325 mg | 2022 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Effervescent | Oral | 325 mg | 2022 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet, Effervescent | Oral | 325 mg | 2025 | |
Indications
| |||||
Western First Aid Safety DBA Aramark | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
Healthdoc LLC | Capsule | Oral | 81 mg | 2023 | |
Indications
| |||||
HealthDoc LLC | Powder | Oral | 81 mg/2 g | 2023 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2015 | |
Indications
| |||||
America Medic & Science, LLC | Tablet, Delayed Release | Oral | 81 mg | 2020 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet, Coated | Oral | 325 mg | 2017 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2017 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2017 | |
Indications
| |||||
Aarkish Pharmaceuticals NJ Inc. | Tablet, Coated | Oral | 81 mg | 2026 | |
Indications
| |||||
Advance Pharmaceutical Inc. | Tablet | Oral | 81 mg | 1999 | |
Indications
| |||||
Advance Pharmaceutical Inc. | Tablet | Oral | 325 mg | 1990 | |
Indications
| |||||
Advance Pharmaceutical Inc. | Tablet | Oral | 325 mg | 2002 | |
Indications
| |||||
Advance Pharmaceutical Inc. | Tablet, Chewable | Oral | 81 mg | 1988 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 81 mg | 2014 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 81 mg | 2014 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 325 mg | 2014 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 81 mg | 2020 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 81 mg | 2014 | |
Indications
| |||||
America Medic & Science | Tablet | Oral | 81 mg | 2017 | |
Indications
| |||||
America Medic & Science, LLC | Tablet, Delayed Release | Oral | 81 mg | 2020 | |
Indications
| |||||
AMERIFOODS TRADING COMPANY | Tablet, Delayed Release | Oral | 81 mg | 2023 | |
Indications
| |||||
Amerisource Bergen | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
Amerisource Bergen | Tablet, Film Coated | Oral | 325 mg | 2021 | |
Indications
| |||||
Amerisource Bergen | Tablet, Delayed Release | Oral | 325 mg | 2019 | |
Indications
| |||||
ARMY AND AIR FORCE EXCHANGE SERVICE | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
ARMY AND AIR FORCE EXCHANGE SERVICE | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Athlete's Needs Inc | Tablet | Oral | 325 mg | 1993 | |
Indications
| |||||
ATLANTIC BIOLOGICALS CORP. | Tablet, Delayed Release | Oral | 81 mg | 2019 | |
Indications
| |||||
Better Living Brands LLC | Tablet, Chewable | Oral | 81 mg | 2023 | |
Indications
| |||||
Better Living Brands, LLC | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Better Living Brands, LLC | Tablet, Chewable | Oral | 81 mg | 2001 | |
Indications
| |||||
Bi-Mart | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Bi-Mart | Tablet, Film Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
BJWC (Berkley & Jensen / BJ's) | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Tablet, Delayed Release | Oral | 325 mg | 2019 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Care One (Retail Business Services, LLC.) | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Chain Drug Consortium | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Chain Drug Marketing Association | Tablet, Delayed Release | Oral | 81 mg | 2018 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Tablet, Film Coated | Oral | 325 mg | 2024 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Tablet, Chewable | Oral | 81 mg | 2025 | |
Indications
| |||||
Cispharma, Inc | Tablet, Coated | Oral | 81 mg | 2011 | |
Indications
| |||||
Cispharma, Inc | Tablet, Coated | Oral | 325 mg | 2010 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet, Film Coated | Oral | 325 mg | 2010 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet, Film Coated | Oral | 325 mg | 2010 | |
Indications
| |||||
COSTCO WHOLESALE CORPORATION | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
CVS Pharmacy | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
CVS Pharmacy | Tablet, Chewable | Oral | 81 mg | 1992 | |
Indications
| |||||
CVS Pharmacy | Tablet, Delayed Release | Oral | 81 mg | 2014 | |
Indications
| |||||
CVS PHARMACY | Tablet, Delayed Release | Oral | 325 mg | 2019 | |
Indications
| |||||
CVS Pharmacy | Tablet, Chewable | Oral | 81 mg | 1997 | |
Indications
| |||||
CVS Pharmacy | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Tablet, Chewable | Oral | 81 mg | 2025 | |
Indications
| |||||
Discount Drug Mart | Tablet, Film Coated | Oral | 325 mg | 2019 | |
Indications
| |||||
DOLGENCORP, LLC | Tablet, Delayed Release | Oral | 81 mg | 2014 | |
Indications
| |||||
DOLGENCORP, LLC | Tablet | Oral | 325 mg | 1993 | |
Indications
| |||||
DOLGENCORP, LLC | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
FOODHOLD U. S. A. , LLC | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
FSA Store Inc. | Tablet, Coated | Oral | 325 mg | 2023 | |
Indications
| |||||
Geiss, Destin & Dunn Inc. | Tablet, Film Coated | Oral | 325 mg | 2023 | |
Indications
| |||||
Genuine First Aid LLC | Tablet | Oral | 325 mg | 2010 | |
Indications
| |||||
Geri-Care Pharmaceuticals, Corp | Tablet | Oral | 325 mg | 1993 | |
Indications
| |||||
GOODSENSE | Tablet, Delayed Release | Oral | 81 mg | 2019 | |
Indications
| |||||
Grocery Outlet | Tablet | Oral | 81 mg | 2026 | |
Indications
| |||||
H E B | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
H-E-B | Tablet, Coated | Oral | 325 mg | 2024 | |
Indications
| |||||
HARRIS TEETER | Tablet, Coated | Oral | 325 mg | 2014 | |
Indications
| |||||
HARRIS TEETER | Tablet, Delayed Release | Oral | 325 mg | 2014 | |
Indications
| |||||
HART Health | Tablet | Oral | 325 mg | 1986 | |
Indications
| |||||
Health Pharma USA, LLC | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
HyVee Inc | Tablet, Chewable | Oral | 81 mg | 1997 | |
Indications
| |||||
INVAHEALTH INC | Tablet, Delayed Release | Oral | 81 mg | 2022 | |
Indications
| |||||
Kareway Product, Inc. | Tablet | Oral | 325 mg | 2011 | |
Indications
| |||||
KEM Pharma LLC | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
KEM Pharma LLC | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Kroger Company | Tablet, Chewable | Oral | 81 mg | 1992 | |
Indications
| |||||
Kroger Company | Tablet, Film Coated | Oral | 325 mg | 2021 | |
Indications
| |||||
Kroger Company | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Chewable | Oral | 81 mg | 1990 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Liberty Pharmaceuticals, Inc. | Tablet, Coated | Oral | 325 ng | 2012 | |
Indications
| |||||
Lodaat LLC | Tablet | Oral | 81 mg | 2023 | |
Indications
| |||||
Major Pharmaceuticals | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Major Pharmaceuticals | Tablet, Chewable | Oral | 81 mg | 2007 | |
Indications
| |||||
Marc Glassman, Inc. | Tablet, Coated | Oral | 325 mg | 2009 | |
Indications
| |||||
Marc Glassman, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2010 | |
Indications
| |||||
Marc Glassman, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2008 | |
Indications
| |||||
Marlex Pharmaceuticals Inc. | Tablet | Oral | 81 mg | 2021 | |
Indications
| |||||
Meijer | Tablet, Coated | Oral | 325 mg | 2015 | |
Indications
| |||||
Meijer Distribution Inc | Tablet, Chewable | Oral | 81 mg | 1992 | |
Indications
| |||||
Meijer Distribution Inc | Tablet, Chewable | Oral | 81 mg | 1996 | |
Indications
| |||||
Meijer Distribution, Inc. | Tablet, Delayed Release | Oral | 325 mg | 2024 | |
Indications
| |||||
Meijer Distribution, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
Meijer Distribution, Inc. | Tablet, Film Coated | Oral | 325 mg | 2024 | |
Indications
| |||||
NORTHEAST PHARMA | Tablet, Film Coated | Oral | 325 mg | 2020 | |
Indications
| |||||
PROSTAT FIRST AID | Tablet | Oral | 325 mg | 2025 | |
Indications
| |||||
Publix Super Markets Inc | Tablet, Chewable | Oral | 81 mg | 1998 | |
Indications
| |||||
PUBLIX SUPER MARKETS INC | Tablet, Coated | Oral | 325 mg | 2020 | |
Indications
| |||||
Publix Super Markets Inc | Tablet, Chewable | Oral | 81 mg | 1999 | |
Indications
| |||||
Publix Supermarkets, Inc. | Tablet | Oral | 81 mg | 2023 | |
Indications
| |||||
Publix Supermarkets, Inc. | Tablet | Oral | 81 mg | 2019 | |
Indications
| |||||
RETAIL BUSINESS SERVICES, LLC. | Tablet, Coated | Oral | 325 mg | 2024 | |
Indications
| |||||
Richmond Pharmaceuticals, Inc | Tablet | Oral | 325 mg | 2015 | |
Indications
| |||||
Richmond Pharmaceuticals, Inc. | Tablet | Oral | 81 mg | 2015 | |
Indications
| |||||
Richmond Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2015 | |
Indications
| |||||
Richmond Pharmaceuticals, Inc. | Tablet, Chewable | Oral | 81 mg | 2015 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Delayed Release | Oral | 325 mg | 2023 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Delayed Release | Oral | 325 mg | 1992 | |
Indications
| |||||
RMT HEALTH LLC | Tablet, Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
Rugby Laboratories | Tablet, Delayed Release | Oral | 81 mg | 2019 | |
Indications
| |||||
Rugby Laboratories | Tablet, Delayed Release | Oral | 325 mg | 2019 | |
Indications
| |||||
Rugby Laboratories | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Safetec of America, Inc. | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
Salado Sales, Inc. | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Sam's West Inc | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Delayed Release | Oral | 81 mg | 2020 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Delayed Release | Oral | 81 mg | 2020 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Delayed Release | Oral | 325 mg | 2020 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Delayed Release | Oral | 81 mg | 2021 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Chewable | Oral | 81 mg | 2018 | |
Indications
| |||||
STRATEGIC SOURCING SERVICES LLC | Tablet, Delayed Release | Oral | 81 mg | 2023 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet, Delayed Release | Oral | 81 mg | 2012 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet | Oral | 81 mg | 2024 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet, Film Coated | Oral | 325 mg | 2023 | |
Indications
| |||||
Sunrise Pharmaceutical Inc | Tablet, Delayed Release | Oral | 81 mg | 2005 | |
Indications
| |||||
Sunrise Pharmaceutical Inc | Tablet, Delayed Release | Oral | 81 mg | 2010 | |
Indications
| |||||
TARGET CORPORATION | Tablet, Coated | Oral | 81 mg | 2020 | |
Indications
| |||||
TIME CAP LABS INC | Tablet, Coated | Oral | 325 mg | 2014 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet, Coated | Oral | 81 mg | 2010 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet, Chewable | Oral | 81 mg | 2010 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet, Delayed Release | Oral | 81 mg/81 1 | 2010 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet | Oral | 81 mg | 2010 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet, Coated | Oral | 500 mg/500 1 | 2013 | |
Indications
| |||||
TOP CARE (Topco Associates LLC) | Tablet, Coated | Oral | 81 mg | 2020 | |
Indications
| |||||
Topco Associates, LLC | Tablet, Delayed Release | Oral | 81 mg | 2021 | |
Indications
| |||||
Topco Associates, LLC | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Trifecta Pharmaceuticals USA LLC | Tablet | Oral | 325 mg | 2024 | |
Indications
| |||||
Trifecta Pharmaceuticals USA LLC | Tablet | Oral | 325 mg | 2025 | |
Indications
| |||||
United Exchange Corp. | Tablet | Oral | 325 mg | 2016 | |
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Delayed Release | Oral | 81 mg | 2014 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Film Coated | Oral | 325 mg | 2006 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Chewable | Oral | 81 mg | 2001 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Chewable | Oral | 81 mg | 1990 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Delayed Release | Oral | 325 mg | 2014 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Coated | Oral | 325 mg | 2023 | |
Indications
| |||||
Valu Merchandisers Company | Tablet, Chewable | Oral | 81 mg | 2001 | |
Indications
| |||||
Valu Merchandisers Company | Tablet | Oral | 325 mg | 1993 | |
Indications
| |||||
Valu Merchandisers Company | Tablet, Delayed Release | Oral | 81 mg | 2021 | |
Indications
| |||||
Velocity Pharma | Tablet | Oral | 81 mg | 2011 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Walgreen Company | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Walgreen Company | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Walgreen Company | Tablet, Chewable | Oral | 81 mg | 1990 | |
Indications
| |||||
Walgreen Company | Tablet, Delayed Release | Oral | 325 mg | 1992 | |
Indications
| |||||
Walgreen Company | Tablet, Delayed Release | Oral | 81 mg | 2009 | |
Indications
| |||||
Walgreen Company | Tablet, Delayed Release | Oral | 81 mg | 2014 | |
Indications
| |||||
Wildman Business Group | Tablet, Coated | Oral | 325 mg | 2024 | |
Indications
| |||||
WinCo Foods LLC | Tablet | Oral | 325 mg | 2022 | |
Indications
| |||||
WinCo Foods, LLC | Tablet, Delayed Release | Oral | 81 mg | 2014 | |
Indications
| |||||
WinCo Foods, LLC | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
WR Group, Inc. | Tablet, Coated | Oral | 81 mg | 2020 | |
Indications
| |||||
Walgreen Company | Tablet, Delayed Release | Oral | 325 mg | 2017 | |
Indications
| |||||
BETTER LIVING BRANDS, LLC | Tablet, Coated | Oral | 325 mg | 2026 | |
Indications
| |||||
HYVEE INC | Tablet, Coated | Oral | 325 mg | 2026 | |
Indications
| |||||
Reliable 1 Laboratories LLC | Tablet | Oral | 325 mg | 2015 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 325 mg | 2022 | |
Indications
| |||||
Reliable 1 Laboratories LLC | Tablet | Oral | 325 mg | 2015 | |
Indications
| |||||
Afassco Inc. | Tablet | Oral | 325 mg | 2015 | |
Indications
| |||||
Provision Medical Products | Tablet | Oral | 325 mg | 2015 | |
Indications
| |||||
JHK Inc dba American Safety & First Aid | Tablet | Oral | 325 mg | 2000 | |
Indications
| |||||
Amerisource Bergen | Tablet, Delayed Release | Oral | 81 mg | 2019 | |
Indications
| |||||
Rising Pharma Holdings, Inc. | Tablet | Oral | 81 mg | 2022 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 81 mg | 2022 | |
Indications
| |||||
Beacon Pharma, Inc. | Tablet, Coated | Oral | 81 mg | 2011 | |
Indications
| |||||
Chain Drug Marketing Association | Tablet, Delayed Release | Oral | 81 mg | 2014 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Delayed Release | Oral | 81 mg | 2024 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
DOLGENCORP, LLC | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
H E B | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
HEB | Tablet, Delayed Release | Oral | 81 mg | 2010 | |
Indications
| |||||
HYVEE INC | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
Lidl US LLC | Tablet, Delayed Release | Oral | 81 mg | 2023 | |
Indications
| |||||
Meijer | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Meijer Distribution Inc | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
NewVue LLC | Tablet, Delayed Release | Oral | 81 mg | 2021 | |
Indications
| |||||
Prodigy Innovation LLC | Tablet, Coated | Oral | 81 mg | 2011 | |
Indications
| |||||
Reliable 1 Laboratories LLC | Tablet, Chewable | Oral | 81 mg | 2015 | |
Indications
| |||||
Reliable 1 Laboratories LLC | Tablet, Coated | Oral | 81 mg | 2020 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Delayed Release | Oral | 81 mg | 2023 | |
Indications
| |||||
Marlex Pharmaceuticals Inc | Tablet | Oral | 81 mg | 2018 | |
Indications
| |||||
Marlex Pharmaceuticals Inc | Tablet | Oral | 81 mg | 2020 | |
Indications
| |||||
Reliable 1 Laboratories LLC | Tablet | Oral | 81 mg | 2018 | |
Indications
| |||||
Allegiant Health | Tablet, Film Coated | Oral | 81 mg | 2024 | |
Indications
| |||||
BETTER LIVING BRANDS LLC. | Tablet, Delayed Release | Oral | 81 mg | 2023 | |
Indications
| |||||
Gendose Pharmaceuticals, LLC | Tablet, Chewable | Oral | 81 mg | 2025 | |
Indications
| |||||
HARRIS TEETER | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Lodaat LLC | Tablet, Chewable | Oral | 81 mg | 2024 | |
Indications
| |||||
Lodaat LLC | Tablet, Chewable | Oral | 81 mg | 2024 | |
Indications
| |||||
Meijer | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Strive Pharmaceuticals Inc. | Tablet | Oral | 81 mg | 2018 | |
Indications
| |||||
Strive Pharmaceuticals Inc. | Tablet | Oral | 81 mg | 2020 | |
Indications
| |||||
TopCare | Tablet, Delayed Release | Oral | 81 mg | 2016 | |
Indications
| |||||
VITANE PHARMACEUTICALS, INC | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
VITANE PHARMACEUTICALS, INC | Tablet | Oral | 81 mg | 2025 | |
Indications
| |||||
Advanced Rx LLC | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
Allegiant Health | Tablet, Delayed Release | Oral | 81 mg | 2021 | |
Indications
| |||||
Allegiant Health | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Allegiant Health | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Dr. Wayne's | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Gendose Pharmaceuticals, LLC | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
HHH PHARMA USA LLC | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
Medline Industries, LP | Tablet, Delayed Release | Oral | 81 mg | 2018 | |
Indications
| |||||
Farmacias De Similares TX LLC | Tablet, Coated | Oral | 81 mg | 2026 | |
Indications
| |||||
AARNA USA INC. | Tablet | Oral | 81 mg | 2025 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet, Film Coated | Oral | 81 mg | 2010 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet, Film Coated | Oral | 81 mg | 2010 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet, Film Coated | Oral | 81 mg | 2010 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet, Film Coated | Oral | 81 mg | 2010 | |
Indications
| |||||
MAJOR PHARMACEUTICALS | Tablet, Coated | Oral | 81 mg | 2018 | |
Indications
| |||||
NUVICARE LLC | Tablet | Oral | 81 mg | 2024 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet, Chewable | Oral | 81 mg | 2010 | |
Indications
| |||||
Cardinal Health 107, LLC | Tablet, Chewable | Oral | 81 mg | 2024 | |
Indications
| |||||
Major Pharmaceuticals | Tablet, Chewable | Oral | 81 mg | 2025 | |
Indications
| |||||
MAJOR PHARMACEUTICALS | Tablet, Chewable | Oral | 81 mg | 2018 | |
Indications
| |||||
Valu Merchandisers Company | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Pioneer Life Sciences, LLC | Tablet | Oral | 81 mg | 2024 | |
Indications
| |||||
Pioneer Life Sciences, LLC | Tablet | Oral | 81 mg | 2021 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Tablet, Delayed Release | Oral | 81 mg | 2022 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Tablet, Delayed Release | Oral | 81 mg | 2022 | |
Indications
| |||||
Ulai Health LLC | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Cambridge Therapeutics Technologies, LLC | Tablet, Coated | Oral | 81 mg | 2011 | |
Indications
| |||||
Amazon. com Services LLC | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet | Oral | 81 mg | 2002 | |
Indications
| |||||
Bayer HealthCare LLC | Powder | Oral | 500 mg | 2015 | |
| |||||
Bayer HealthCare LLC. | Tablet | Oral | 500 mg | 2014 | |
Indications
| |||||
Savings Distributors LLC | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet, Coated | Oral | 325 mg | 2015 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet, Chewable | Oral | 81 mg | 2015 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet, Chewable | Oral | 81 mg | 2002 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet | Oral | 325 mg | 2014 | |
Indications
| |||||
JC World Bell Wholesale Co. , Inc. | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
JC World Bell Wholesale Co. , Inc. | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Coated | Oral | 325 mg | 2002 | |
Indications
| |||||
Select Corporation | Tablet | Oral | 325 mg | 2014 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Coated | Oral | 325 mg | 2014 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet | Oral | 325 mg | 2009 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Effervescent | Oral | 325 mg | 2024 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Tablet, Film Coated | Oral | 325 mg | 1990 | |
Indications
| |||||
Dr. Reddy's Laboratories Inc. | Tablet | Oral | 325 mg | 2016 | |
Indications
| |||||
Genomma Lab USA | Tablet, Coated | Oral | 325 mg | 2021 | |
Indications
| |||||
OPMX LLC | Tablet, Coated | Oral | 81 mg | 2023 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet | Oral | 81 mg | 2001 | |
| |||||
New World Imports, Inc | Tablet, Coated | Oral | 81 mg | 2020 | |
Indications
| |||||
New World Imports, Inc | Tablet, Chewable | Oral | 81 mg | 2016 | |
Indications
| |||||
Raritan Pharmaceuticals Inc | Tablet, Chewable | Oral | 81 mg | 2013 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Tablet, Chewable | Oral | 81 mg | 2024 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
Genuine First Aid LLC | Tablet, Chewable | Oral | 81 mg | 2010 | |
Indications
| |||||
Grocery Outlet | Tablet, Chewable | Oral | 81 mg | 2026 | |
Indications
| |||||
HARRIS TEETER | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
MARC GLASSMAN, INC. | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
RETAIL BUSINESS SERVICES, LLC. | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
HYVEE INC | Tablet, Chewable | Oral | 81 mg | 2026 | |
Indications
| |||||
Ulai Health LLC | Tablet, Chewable | Oral | 81 mg | 2019 | |
Indications
| |||||
TARGET CORPORATION | Tablet, Chewable | Oral | 81 mg | 2024 | |
Indications
| |||||
We Care Distributor Inc. | Tablet | Oral | 81 mg | 2016 | |
Indications
| |||||
Lil Drug Store Products, Inc | Tablet | Oral | 325 mg | 2017 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Film Coated | Oral | 325 mg | 2019 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet, Coated | Oral | 81 mg | 2001 | |
| |||||
Thompson |
| Oral | 325 mg | 2020 | |
Indications
| |||||
Breakthrough Products Inc. | Powder | Oral | 325 mg | 2012 | |
Indications
| |||||
CVS PHARMACY | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
Dolgencorp, LLC | Tablet, Chewable | Oral | 81 mg | 2009 | |
Indications
| |||||
Direct Safety |
| Oral | 325 mg | 2021 | |
Indications
| |||||
Dolgencorp, Inc | Tablet, Effervescent | Oral | 325 mg | 2024 | |
Indications
| |||||
Wayne Pharmaceuticals Inc | Tablet, Delayed Release | Oral | 81 mg | 2019 | |
Indications
| |||||
Discount Drug Mart Inc | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 81 mg | 2022 | |
Indications
| |||||
Medtech Products Inc. | Tablet, Coated | Oral | 81 mg | 2012 | |
Indications
| |||||
Medtech Products Inc. | Tablet, Coated | Oral | 81 mg | 2012 | |
Indications
| |||||
Medtech Products Inc. | Tablet, Coated | Oral | 325 mg | 2012 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Delayed Release | Oral | 325 mg | 1992 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Tablet, Delayed Release | Oral | 325 mg | 2024 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Delayed Release | Oral | 325 mg | 2010 | |
Indications
| |||||
Magno-Humphries, Inc. | Tablet | Oral | 81 mg | 2020 | |
Indications
| |||||
Safeway | Tablet, Delayed Release | Oral | 325 mg | 2015 | |
Indications
| |||||
STRATEGIC SOURCING SERVICES LLC | Tablet, Delayed Release | Oral | 325 mg | 2023 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet, Delayed Release | Oral | 325 mg/325 1 | 2011 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Delayed Release | Oral | 325 mg | 2017 | |
Indications
| |||||
UNITED NATURAL FOODS, INC. DBA UNFI | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Chewable | Oral | 81 mg | 2003 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Chewable | Oral | 81 mg | 2003 | |
Indications
| |||||
HHH PHARMA USA LLC | Tablet, Film Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
HealthLife of USA LLC | Tablet, Film Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
FAMILY WELLNESS SERVICES, INC. | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
Nobel Laboratories, LLC | Tablet, Orally Disintegrating | Oral | 81 mg | 2006 | |
Indications
| |||||
Cintas Corp | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet, Chewable | Oral | 81 mg | 2023 | |
Indications
| |||||
Pioneer Life Sciences, LLC | Tablet | Oral | 81 mg | 2024 | |
Indications
| |||||
Geritrex LLC | Tablet, Coated | Oral | 325 mg | 2018 | |
Indications
| |||||
Amerisource Bergen | Tablet, Chewable | Oral | 81 mg | 1997 | |
Indications
| |||||
Amerisource Bergen | Tablet, Chewable | Oral | 81 mg | 1993 | |
Indications
| |||||
L. Perrigo Company | Tablet, Chewable | Oral | 81 mg | 1997 | |
Indications
| |||||
L. Perrigo Company | Tablet, Chewable | Oral | 81 mg | 1992 | |
Indications
| |||||
Perrigo Direct, Inc. | Tablet, Effervescent | Oral | 325 mg | 2024 | |
Indications
| |||||
Unifirst First Aid Corporaiton | Tablet, Chewable | Oral | 81 mg | 2024 | |
Indications
| |||||
H. E. BUTT GROCERY COMPANY | Tablet, Effervescent | Oral | 325 mg | 2024 | |
Indications
| |||||
Cardinal Health 110, LLC. dba Leader | Tablet, Chewable | Oral | 81 mg | 2018 | |
Indications
| |||||
Cardinal Health 110, LLC. dba Leader | Tablet, Chewable | Oral | 81 mg | 2018 | |
Indications
| |||||
Lil Drug Store Products, Inc | Tablet | Oral | 325 mg | 2016 | |
Indications
| |||||
Akron Phama | Tablet, Coated | Oral | 81 mg | 2024 | |
Indications
| |||||
Akron Phama | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Akron Phama | Tablet, Coated | Oral | 81 mg | 2024 | |
Indications
| |||||
BJWC (Berkley & Jensen / BJ's) | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
Family Dollar Services Inc | Tablet, Delayed Release | Oral | 81 mg | 2019 | |
Indications
| |||||
H E B | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Hy-Vee | Tablet, Coated | Oral | 81 mg | 2025 | |
Indications
| |||||
P & L Development, LLC | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Pharbest Pharmaceuticals, Inc. | Tablet, Chewable | Oral | 81 mg | 2007 | |
Indications
| |||||
RETAIL BUSINESS SERVICES, LLC. | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
SAM'S WEST INC | Tablet, Coated | Oral | 81 mg | 2024 | |
Indications
| |||||
Spirit Pharmaceuticals LLC | Tablet, Delayed Release | Oral | 81 mg | 2023 | |
| |||||
Strategic Sourcing Services LLC | Tablet, Coated | Oral | 81 mg | 2023 | |
Indications
| |||||
TIME CAP LABORATORIES, INC | Tablet, Coated | Oral | 81 mg | 2015 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet, Delayed Release | Oral | 81 mg | 2010 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet, Delayed Release | Oral | 81 mg | 2010 | |
Indications
| |||||
Topco Associates | Tablet, Coated | Oral | 81 mg | 2023 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Delayed Release | Oral | 81 mg | 2020 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Delayed Release | Oral | 81 mg | 2011 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 81 mg | 2021 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 81 mg | 2021 | |
Indications
| |||||
Walmart Inc. | Tablet, Coated | Oral | 81 mg | 2024 | |
Indications
| |||||
WinCo Foods, LLC | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
BETTER LIVING BRANDS LLC. | Tablet | Oral | 81 mg | 2023 | |
Indications
| |||||
AMERIFOODS TRADING COMPANY | Tablet, Chewable | Oral | 81 mg | 2025 | |
Indications
| |||||
Bi-Mart | Tablet, Chewable | Oral | 81 mg | 2025 | |
Indications
| |||||
FSA STORE INC. | Tablet, Chewable | Oral | 81 mg | 2023 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Chewable | Oral | 81 mg | 2021 | |
Indications
| |||||
Time-Cap Labs, Inc | Tablet, Delayed Release | Oral | 81 mg | 2010 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet, Chewable | Oral | 81 mg | 1995 | |
Indications
| |||||
DEMOULAS SUPER MARKETS, INC. | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
McKesson Medical-Surgical | Tablet, Film Coated | Oral | 325 mg | 2022 | |
Indications
| |||||
Unifirst First Aid Corporation |
| Oral | 325 mg | 2020 | |
Indications
| |||||
Sportpharm, Inc. dba Sportpharm | Tablet, Film Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Film Coated | Oral | 325 mg | 2021 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Effervescent | Oral | 325 mg | 2025 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Chewable | Oral | 81 mg | 2024 | |
Indications
| |||||
Meijer Distribution Inc | Tablet, Effervescent | Oral | 325 mg | 2024 | |
Indications
| |||||
Meijer, Inc. | Tablet, Coated | Oral | 81 mg | 2024 | |
Indications
| |||||
Noble Otc LLC | Tablet, Delayed Release | Oral | 81 mg | 2021 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Delayed Release | Oral | 81 mg | 2008 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Chewable | Oral | 81 mg | 2001 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Film Coated | Oral | 325 mg | 1996 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Delayed Release | Oral | 81 mg | 2014 | |
Indications
| |||||
Health Pharma USA, LLC | Tablet, Delayed Release | Oral | 81 mg | 2025 | |
Indications
| |||||
Spirit Pharmaceuticals LLC | Tablet, Coated | Oral | 325 mg | 2021 | |
Indications
| |||||
Spirit Pharmaceuticals LLC | Tablet, Coated | Oral | 81 mg | 2021 | |
Indications
| |||||
Pharbest Pharmaceuticals, Inc. | Tablet, Delayed Release | Oral | 325 mg | 2010 | |
Indications
| |||||
Pharbest Pharmaceuticals, Inc | Tablet | Oral | 325 mg | 2007 | |
Indications
| |||||
Acme United Corporation |
| Oral | 325 mg | 2020 | |
Indications
| |||||
PUBLIX SUPER MARKETS INC. | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
Lab Safety Supply, Inc. | Tablet, Film Coated | Oral | 325 mg | 2011 | |
Indications
| |||||
Pharmadel LLC | Tablet, Coated | Oral | 325 mg | 2023 | |
Indications
| |||||
Kroger | Tablet, Coated | Oral | 325 mg | 2024 | |
Indications
| |||||
CARDINAL HEALTH, INC. | Tablet, Coated | Oral | 325 mg | 2019 | |
Indications
| |||||
TARGET CORPORATION | Tablet | Oral | 325 mg | 2022 | |
Indications
| |||||
Aidarex Pharmaceuticals LLC | Tablet, Delayed Release | Oral | 325 mg | 2011 | |
Indications
| |||||
H. J. Harkins Company, Inc. | Tablet, Delayed Release | Oral | 325 mg | 2011 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet, Coated | Oral | 325 mg | 2000 | |
Indications
| |||||
NORTHEAST PHARMA | Tablet, Coated | Oral | 325 mg | 2000 | |
Indications
| |||||
Strive Pharmaceuticals Inc | Tablet | Oral | 81 mg | 2021 | |
Indications
| |||||
Strive Pharmaceuticals Inc. | Tablet | Oral | 81 mg | 2025 | |
Indications
| |||||
Rugby Laboratories | Tablet, Chewable | Oral | 81 mg | 2014 | |
Indications
| |||||
Ulai Health LLC | Tablet, Delayed Release | Oral | 325 mg | 2019 | |
Indications
| |||||
Ulai Health LLC | Tablet, Delayed Release | Oral | 81 mg | 2019 | |
Indications
| |||||
Safeway Inc. | Tablet, Effervescent | Oral | 325 mg | 2024 | |
Indications
| |||||
Pace Wellness Inc. | Strip | Oral | 81 mg | 2014 | |
Indications
| |||||
Pace Wellness Inc. | Strip | Oral | 81 mg | 2014 | |
Indications
| |||||
Foundation Consumer Healthcare LLC | Tablet, Chewable | Oral | 81 mg | 2017 | |
Indications
| |||||
Foundation Consumer Healthcare | Tablet, Film Coated | Oral | 81 mg | 2017 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet, Chewable | Oral | 81 mg | 2003 | |
Indications
| |||||
Topco Associates LLC | Tablet, Chewable | Oral | 81 mg | 1992 | |
Indications
| |||||
Topco Associates LLC | Tablet, Chewable | Oral | 81 mg | 2005 | |
Indications
| |||||
TOPCO ASSOCIATES LLC | Tablet, Effervescent | Oral | 325 mg | 2023 | |
Indications
| |||||
Bellegrove Medical Supply, Inc. | Tablet, Coated | Oral | 325 mg | 2021 | |
Indications
| |||||
Major Pharmaceuticals | Tablet, Film Coated | Oral | 325 mg | 1990 | |
Indications
| |||||
ULINE |
| Oral | 325 mg | 2020 | |
Indications
| |||||
Unishield |
| Oral | 325 mg | 2021 | |
Indications
| |||||
Target Corporation | Tablet, Chewable | Oral | 81 mg | 2015 | |
Indications
| |||||
Ajes Pharmaceuticals, LLC | Tablet | Oral | 81 mg/81 mg | 2012 | |
Indications
| |||||
Ajes Pharmaceuticals, LLC | Tablet | Oral | 81 mg/81 mg | 2012 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Delayed Release | Oral | 325 mg | 2020 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Delayed Release | Oral | 325 mg | 2018 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Delayed Release | Oral | 81 mg | 2017 | |
Indications
| |||||
PLx Pharma Inc | Capsule | Oral | 325 mg/325 mg | 2021 | |
Indications
| |||||
PLx Pharma Inc | Capsule | Oral | 81 mg/81 mg | 2021 | |
Indications
| |||||
Winco Foods, LLC | Tablet, Effervescent | Oral | 325 mg | 2024 | |
Indications
| |||||
Cintas Corporation | Tablet, Chewable | Oral | 81 mg | 2025 | |
Indications
| |||||
Repacked & Relabeled Product Labels
The table below lists products marketed under repackaged or relabeled National Drug Codes (NDCs).
Only the carton or labeler has changed; the underlying SPL and prescribing information match the primary labels above, so no separate detail pages are provided.
Below are the non-prescription pack sizes of Low Dose Aspirin (aspirin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Label | Forms | Routes | Aspirin | FDA year |
|---|---|---|---|---|
4Medical Group, LLC | Tablet | Oral | 81 mg | 2023 |
4Medical Group LLC | Tablet, Coated | Oral | 81 mg | 2023 |
A-S Medication Solutions | Tablet, Delayed Release | Oral | 81 mg | 2007 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet, Delayed Release | Oral | 81 mg | 2025 |
NuCare Pharmaceuticals, Inc. | Tablet, Coated | Oral | 81 mg | 2000 |
Preferred Pharmaceuticals Inc. | Tablet, Coated | Oral | 81 mg | 2024 |
Preferred Pharmaceuticals Inc. | Tablet, Coated | Oral | 81 mg | 2024 |
ST. MARY'S MEDICAL PARK PHARMACY | Tablet, Coated | Oral | 81 mg | 2000 |
TYA Pharmaceuticals | Tablet, Coated | Oral | 81 mg | 2000 |
Navajo Manufacturing Company Inc. | Tablet, Effervescent | Oral | 325 mg | 2023 |
Unit Dose Services | Tablet | Oral | 81 mg | 2011 |
A-S Medication Solutions | Tablet, Film Coated | Oral | 325 mg | 1996 |
A-S Medication Solutions | Tablet | Oral | 81 mg | 2014 |
A-S Medication Solutions | Tablet, Delayed Release | Oral | 81 mg | 2019 |
A-S Medication Solutions | Tablet, Delayed Release | Oral | 81 mg | 2019 |
A-S Medication Solutions | Tablet, Chewable | Oral | 81 mg | 2007 |
A-S Medication Solutions | Tablet, Delayed Release | Oral | 81 mg | 2019 |
A-S Medication Solutions | Tablet, Delayed Release | Oral | 81 mg | 2019 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 1993 |
A-S Medication Solutions | Tablet, Coated | Oral | 81 mg | 2010 |
Advanced Rx Pharmacy of Tennessee, LLC | Tablet, Coated | Oral | 325 mg | 2023 |
Allegiant Health | Tablet | Oral | 325 mg | 2014 |
America Medic | Tablet | Oral | 81 mg | 2012 |
America's Pharmacy Source LLC | Tablet, Delayed Release | Oral | 81 mg | 2019 |
Aphena Pharma Solutions - Tennessee, LLC | Tablet | Oral | 325 mg | 2015 |
Apotheca, Inc | Tablet | Oral | 325 g | 1983 |
Atlantic Biologicals Corps | Tablet | Oral | 325 mg | 1993 |
Bryant Ranch Prepack | Tablet, Coated | Oral | 81 mg | 2000 |
Carilion Materials Management | Tablet | Oral | 81 mg | 2009 |
Central Texas Community Health Centers | Tablet | Oral | 325 mg | 2014 |
HF Acquisition Co LLC, DBA HealthFirst | Tablet, Film Coated | Oral | 325 mg | 1996 |
NuCare Pharmaceuticals, Inc. | Tablet, Coated | Oral | 81 mg | 2021 |
NuCare Pharmaceuticals, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2019 |
NuCare Pharmaceuticals, Inc. | Tablet, Coated | Oral | 81 mg | 2021 |
NuCare Pharmaceuticals, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2011 |
NuCare Pharmceuticals, Inc. | Tablet, Coated | Oral | 325 mg | 2000 |
PD-Rx Pharmaceuticals, Inc. | Tablet, Delayed Release | Oral | 81 mg | 2019 |
Physicians Total Care, Inc. | Tablet, Chewable | Oral | 81 mg | 2007 |
Physicians Total Care, Inc. | Tablet | Oral | 325 mg | 1995 |
Physicians Total Care, Inc. | Tablet, Coated | Oral | 81–325 mg | 1993 |
Preferred Pharmaceuticals Inc. | Tablet, Delayed Release | Oral | 81 mg | 2019 |
Preferred Pharmaceuticals Inc. | Tablet, Delayed Release | Oral | 81 mg | 2024 |
Preferred Pharmaceuticals Inc. | Tablet, Delayed Release | Oral | 81 mg | 2023 |
Preferred Pharmaceuticals Inc. | Tablet | Oral | 325 mg | 2022 |
Proficient Rx LP | Tablet | Oral | 325 mg | 2024 |
Proficient Rx LP | Tablet, Chewable | Oral | 81 mg | 2007 |
Proficient Rx LP | Tablet, Film Coated | Oral | 325 mg | 1996 |
Rebel Distributors Corp | Tablet | Oral | 325 mg | 2008 |
Safecor Health, LLC | Tablet | Oral | 81 mg | 2022 |
Sina Health Inc | Tablet, Film Coated | Oral | 325 mg | 2011 |
ST. MARY'S MEDICAL PARK PHARMACY | Tablet | Oral | 325 mg | 1993 |
St. Mary's Medical Park Pharmacy | Tablet, Film Coated | Oral | 325 mg | 2021 |
State of Florida DOH Central Pharmacy | Tablet | Oral | 325 mg | 2014 |
Bryant Ranch Prepack | Tablet | Oral | 325 mg | 2015 |
Denton Pharma, Inc. dba Northwind Pharmaceuticals | Tablet | Oral | 325 mg | 2020 |
Proficient Rx LP | Tablet | Oral | 325 mg | 2015 |
A-S Medication Solutions | Tablet, Coated | Oral | 81 mg | 2020 |
Asclemed USA, Inc. | Tablet, Coated | Oral | 81 mg | 2022 |
Bryant Ranch Prepack | Tablet, Coated | Oral | 81 mg | 2020 |
Aphena Pharma Solutions - Tennessee, LLC | Tablet, Coated | Oral | 81 mg | 1994 |
Rebel Distributors Corp | Tablet, Coated | Oral | 81 mg | 1993 |
A-S Medication Solutions | Tablet, Chewable | Oral | 81 mg | 2018 |
A-S Medication Solutions | Tablet, Chewable | Oral | 81 mg | 2018 |
Proficient Rx LP | Tablet, Chewable | Oral | 81 mg | 2018 |
HF Acquisition Co LLC, DBA HealthFirst | Tablet, Chewable | Oral | 81 mg | 2018 |
Sina Health Inc | Tablet, Film Coated | Oral | 325 mg | 2020 |
HF Acquisition Co LLC, DBA HealthFirst | Tablet, Film Coated | Oral | 325 mg | 2015 |
Acme United Corporation | Tablet | Oral | 325 mg | 2023 |
Navajo Manufacturing Company Inc. | Tablet | Oral | 325 mg | 2016 |
R J General Corporation | Tablet | Oral | 325 mg | 2014 |
Select Consumer Group | Tablet | Oral | 325 mg | 2014 |
Your Safety Company | Tablet | Oral | 325 mg | 2016 |
A-S Medication Solutions | Tablet, Delayed Release | Oral | 325 mg/325 1 | 2011 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2011 |
Bryant Ranch Prepack | Tablet, Delayed Release | Oral | 325 mg | 2011 |
McKesson Corporation dba SKY Packaging | Tablet, Delayed Release | Oral | 325 mg/325 1 | 2011 |
Rebel Distributors Corp | Tablet, Delayed Release | Oral | 325 mg | 2011 |
State of Florida DOH Central Pharmacy | Tablet | Oral | 325 mg | 2014 |
A-S Medication Solutions | Tablet, Chewable | Oral | 81 mg | 1992 |
Proficient Rx LP | Tablet, Chewable | Oral | 81 mg | 1992 |
A-S Medication Solutions | Tablet, Chewable | Oral | 81 mg | 2007 |
A-S Medication Solutions | Tablet, Coated | Oral | 81 mg | 2015 |
A-S Medication Solutions | Tablet, Coated | Oral | 81 mg | 2015 |
A-S Medication Solutions | Tablet, Coated | Oral | 81 mg | 2015 |
Bryant Ranch Prepack | Tablet, Coated | Oral | 81 mg | 2015 |
Bryant Ranch Prepack | Tablet, Coated | Oral | 81 mg | 2015 |
Bryant Ranch Prepack | Tablet, Coated | Oral | 81 mg | 2015 |
Bryant Ranch Prepack | Tablet, Coated | Oral | 81 mg | 2015 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet, Coated | Oral | 81 mg | 2015 |
NuCare Pharmaceuticals, Inc. | Tablet, Coated | Oral | 81 mg | 2015 |
NuCare Pharmaceuticals, Inc. | Tablet, Coated | Oral | 81 mg | 2015 |
Proficient Rx LP | Tablet, Coated | Oral | 81 mg | 2015 |
HF Acquisition Co LLC, DBA HealthFirst | Tablet, Film Coated | Oral | 325 mg | 2008 |
PURINEPHARMA LLC | Tablet | Oral | 81 mg | 2015 |
Contract Pharmacy Services-PA | Tablet, Delayed Release | Oral | 325 mg | 2017 |
TYA Pharmaceuticals | Tablet | Oral | 81 mg | 2014 |
A-S Medication Solutions | Tablet, Delayed Release | Oral | 325 mg | 2011 |
Aphena Pharma Solutions - Tennessee, LLC | Tablet, Delayed Release | Oral | 325 mg | 2011 |
Contract Pharmacy Services-PA | Tablet, Delayed Release | Oral | 325 mg | 2011 |
A-S Medication Solutions | Tablet, Coated | Oral | 325 mg | 2000 |
A-S Medication Solutions | Tablet, Coated | Oral | 325 mg | 2000 |
Bryant Ranch Prepack | Tablet, Coated | Oral | 325 mg | 2000 |
ST. MARY'S MEDICAL PARK PHARMACY | Tablet, Coated | Oral | 325 mg | 2000 |
Central Texas Community Health Centers | Tablet, Chewable | Oral | 81 mg | 2003 |
Central Texas Community Health Centers | Tablet, Chewable | Oral | 81 mg | 2003 |
Proficient Rx LP | Tablet, Film Coated | Oral | 325 mg | 1990 |
Ajes Pharmaceuticals, LLC | Tablet | Oral | 325 mg/325 mg | 2012 |
Ajes Pharmaceuticals, LLC | Tablet | Oral | 325 mg/325 mg | 2012 |